Nanobodies unlock new mechanisms to target G protein-coupled receptors
Molecular Pharmacology · 2026-04 · 108 (4) · 100110
DOI: 10.1016/j.molpha.2026.100110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmacology, 2026-04. Verfasst von Meredith A Skiba. Beteiligte Einrichtung: Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, Michigan; Department of Pharmacology, University of Michiga…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, Michigan; Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan. Electronic address: skibam@…
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Skiba, M. A. (2026). Nanobodies unlock new mechanisms to target G protein-coupled receptors. Molecular Pharmacology, 108(4), 100110. https://doi.org/10.1016/j.molpha.2026.100110
Vancouver
Skiba MA. Nanobodies unlock new mechanisms to target G protein-coupled receptors. Molecular Pharmacology. 2026;108(4):100110. doi:10.1016/j.molpha.2026.100110
BibTeX
@article{Skiba2026,
author = {Skiba, Meredith A},
title = {Nanobodies unlock new mechanisms to target G protein-coupled receptors},
journal = {Molecular Pharmacology},
year = {2026},
volume = {108},
number = {4},
pages = {100110},
doi = {10.1016/j.molpha.2026.100110}
}
EUVIMED